Related Experiment Videos
Nimesulide and renal impairment
R Leone1, A Conforti, E Ghiotto
1Clinical Pharmacology Unit, Institute of Pharmacology, Policlinico B.go Roma, University of Verona, Italy. leone@farma.univr.it
European Journal of Clinical Pharmacology
|May 21, 1999
Summary
Nimesulide, a non-steroidal anti-inflammatory drug, has been linked to renal adverse reactions in spontaneous reports. Healthcare providers should monitor for kidney impairment signs during nimesulide therapy.
Area of Science:
- Pharmacovigilance
- Nephrology
- Drug Safety
Background:
- Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) with selective cyclooxygenase-2 (COX-2) inhibition.
- Spontaneous reporting systems are crucial for detecting post-marketing adverse drug reactions.
- Renal adverse events are a potential concern with NSAID use.
Observation:
- A review of spontaneous reports from the Veneto Pharmacovigilance System (1988-1997) identified cases of renal adverse reactions associated with oral nimesulide.
- Eleven reports specifically detailed suspected renal adverse events.
- In most cases, nimesulide was taken for a short duration, and patients required discontinuation of the drug, with some necessitating hospitalization.
Findings:
- The analysis revealed a signal for renal adverse reactions linked to nimesulide use.
- Co-existing risk factors were identified in some of the reported cases.
- The findings highlight the need for vigilance regarding potential kidney damage.
Implications:
- These findings underscore the importance of recognizing early signs of renal impairment in patients using nimesulide.
- Further epidemiological studies are needed to fully elucidate the extent of nimesulide's renal toxicity.
- Clinicians and patients should be aware of the potential renal risks associated with nimesulide therapy.